Thus, the ROS/PKC-ε/caspase 3 pathway is a possible mechanism that CHE uses to inhibit the growth of HCC827 tumor cells, and this finding might provide insight into the mechanism of CHE’s antitumor effect. Here, PRKCE is linked to neoplasm.